Author | Marco Meglio


Ocrelizumab Shows Benefit in Patients With Relapsing MS and Prior DMT Exposure

September 22, 2020

A study presented at MS Virtual reveals that treatment with ocrelizumab can improve freedom of individual events in patients with relapsing-remitting multiple sclerosis.

Progressive and Relapsing-Remitting Multiple Sclerosis Share Similar Fatigue Severity

September 21, 2020

Future research may help better characterize whether fatigue interventions aimed at one patient population may be effective in the other.

World Alzheimer’s Day 2020: The Latest News and Commentary on the Treatment of Alzheimer Disease

September 21, 2020

In honor of World Alzheimer’s Day, NeurologyLive is sharing some of the latest clinical developments and thoughts from leaders in the field.

Ozanimod Shows Long-Term Safety, Efficacy in Open-Label Extension

September 18, 2020

Along with being generally well tolerated, ozanimod was able to help most patients become relapse free without disability progression.